GLIOMAS
Astrocytic tumors
Pilocytic astrocytoma
Pituicytoma (**)
Pilomyxoid astrocytoma (**)
Subependymal giant cell astrocytoma
Pleomorphic xanthoastrocytoma
Diffuse astrocytoma
Fibrillary astrocytoma
Gemistocytic astrocytoma
Protoplasmic astrocytoma
Anaplastic astrocytoma
Glioblastoma
- Giant cell glioblastoma
- Gliosarcoma
Gliomatosis cerebri
grad
e
II
III
IV
nd
*
*
*
*
*
*
*
*
*
*
*
*
Oligodendroglial tumors
Oligodendroglioma
Anaplastic oligodendroglioma
Oligoastrocytic tumors
Oligoastrocytoma
Anaplastic oligoastrocytoma
Ependymal tumors
Subependymom
Myxopapillary ependymoma
Ependymoma
- Cellular
- Papillary
- Clear Cell
- Tanycytic
Anaplastic ependymoma
nd = not defined
grad
e
II
III
IV
*
*
Etiology
>70% of all primary brain tumors.
The most common (65%) and most malignant
type is glioblastoma.
With the exception of pilocytic astrocytomas, the
prognosis of glioma patients is still poor. Less
than 3% of glioblastoma patients are still alive at
5 years after diagnosis, higher age being the
most significant predictor of poor outcome.
Population-based data of incidence rates, age and sex, and survival of patients with gliomas. From:
Ohgaki H and Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005, 109: 93-108
Epidemiology
Epidemiologic factors including specific
occupational exposures, environmental
carcinogens, foods containing N-nitroso
compounds, electromagnetic fields, etc. have
been associated to only a small proportion of
gliomas.
The only two firmly established factors of
primary brain tumors are the exposure to high
doses of ionizing radiation and inherited
mutations of highly penetrant genes associated
with rare syndromes
Inherited mutations in members of families at increased risk of glioma. From Epidemiology and
molecular pathology of glioma. Schwartzbaum JA, Fisher JL, Aldape KD and Wrensch M. Nat Clinical
Practice Neurology 2006, 9:494-503.
Astrocytic tumour
Pilocytic astrocytoma
Pilocytic astrocytomas correspond to WHO grade I.
A relatively circumscribed, slowly growing, often cystic
astrocytoma occurring in children and young adults.
Approximately 56% of all gliomas with an overall
incidence of 0.37 per 100 000 persons per year.
The most common glioma in children, in whom the
majority arise in the cerebellum.
Localization
Optic nerve
Optic chiasm/hypothalamus
Thalamus and basal ganglia
Cerebral hemispheres
Cerebellum
Brain stem
Spinal cord (in children represent about 11% of spinal
tumours)
Macroscopy
Soft, grey and rather discrete
Cyst formation (intra or paratumoura)
Syrinx formation can extend over many segments (in
spinal cord )
Contain calcium or haemosiderin deposits
(chronic lesions)
Collar-like
Primary diffuse
leptomeningeal pilocytic
astrocytoma is a rarity
Pilocytic astrocytoma.
Granular eosinophilic bodies.
Pilomyxoid astrocytoma
Corresponds to a WHO grade II neoplasm.
Prominent mucoid matrix and angiocentric
arrangement of monomorphous, bipolar tumour cells,
typically without Rosenthal fibers or eosinophilic
granular bodies/ hyaline droplets.
Presents in the very young (median 10 months), but
can occur in older children, rare in adults.
Male / female : roughly equal.
Localization
The hypothalamic/chiasmatic region is the most
common location.
The thalamus
Cerebellum
Brain stem
Temporal lobe
Spinal cord
Macroscopy
Histopathology
Markedly mucoid matrix
Monomorphous bipolar cells,
and a predominantly
angiocentric cell
arrangement.
Compact, rather solid
architecture, but some are
infiltrative.
Monomorphous, intermediate
size, bipolar
Cells may be also aligned
along the long axis of vessels.
Pilomyxoid astrocytoma. H&E stain
demonstrates small piloid cells in a
mucopolysaccharide matrix
Pleomorphic xanthoastrocytoma
Corresponds to a WHO grade II neoplasm
Typically encountered in children and young adults,
with superficial location in the cerebral hemispheres
and involvement of the meninges.
Expressing GFAP and often surrounded by a reticulin
network as well as eosinophilic granular bodies.
Localization
Involving the meninges and cerebrum.
Ninetyeight percent occur supratentorially, in particular
the temporal lobe.
Cases involving the cerebellum and spinal cord are also
on record.
Two children with primary pleomorphic
xanthoastrocytoma of the retina were reported.
Clinical features
Fairly long history of seizures
Symptoms reflect the sites of involvement
CT and MRI scans usually outline the tumour mass
and/or its cyst.
Macroscopy
Attached to the meninges.
Accompanied by a cyst, sometimes forming a mural
nodule within the cyst wall.
Invasion of the dura, predominantly exophytic growth,
multicentricity, leptomeningeal dissemination.
Histopathology
Well established
Pleomorphic refers to the variable histological
appearance of the tumour, in which spindly elements
are intermingled with mono- or multinucleated giant
astrocytes, the nuclei of which show great variation in
size and staining. Intranuclear inclusions are frequent.
Pleomorphic
xanthoastrocytoma.
Xanthic cells, expressed as
vacuolization of the neoplastic
cells, are shown
Immunohistochemistry
GFAP and S-100 protein
Synaptophysin, neurofilament, class III -tubulin and
MAP2
CD34 is frequently expressed in pleomorphic
xanthoastrocytoma cells.
Synaptophysin immunostaining in
PXA cells
Diffuse astrocytoma
Corresponds to a WHO grade II neoplasm
Diffuse astrocytoma
- Fibrillary astrocytoma
- Gemistocytic astrocytoma
- Protoplasmic astrocytoma
Represents 1015% of all astrocytic brain tumours,
approximately 1.4 new cases / 1 million population a
year
Localization
Located in any region of the CNS
Most commonly develops supratentorially in the frontal
and temporal cerebral lobes of both children and adults
(one third of cases each).
The brain stem and spinal cord
Uncommon in the cerebellum.
Clinical features
Seizures
Speech difficulties,
Changes in sensation, vision
Motor change may have been present earlier.
Changes in behaviour
Macroscopy
Local mass lesions.
Indistinct boundaries.
Smaller or larger cysts, granular areas and zones of
firmness or softening.
Single, large cyst filled
with clear fluid.
Single, large
smoothwalled cysts.
Focal calcification.
Histopathology
Well differentiated fibrillary or gemistocytic neoplastic
astrocytes on the background of a loosely structured,
often microcystic tumour matrix.
Cellularity is moderately increased and occasional
nuclear atypia.
Contains astrocytes that are increased in number and
also usually in size.
Fibrillary astrocytoma
This most frequent histological variant of astrocytoma.
Nuclear atypia is a diagnostic criterion but mitotic
activity, necrosis and microvascular proliferation are
absent.
Nuclear atypia is a histological hallmark distinguishing
tumour cells from normal and reactive astrocytes.
Gemistocytic astrocytoma
Conspicuous, though variable, fraction of gemistocytic
neoplastic astrocytes.
More than approximately 20% of all tumour cells.
Plump, glassy, eosinophilic cell bodies of angular shape.
Stout, randomly oriented processes,
forming a coarse fibrillary network.
Characteristic feature of
perivascular lymphocytic
infiltrate
Protoplasmic astrocytoma
Composed of neoplastic astrocytes showing a small cell body
with a few flaccid processes with a low content of glial
filaments and scant GFAP expression.
Cellularity is low and mitotic activity absent.
Mucoid degeneration and microcyst formation are common
and characteristic features.
Nuclei are uniformly round
to oval.
Protoplasmic astrocytoma
showing extensive mucoid
degeneration.
Anaplastic astrocytoma
Corresponds to WHO grade III.
Diffusely infiltrating, malignant astrocytoma
Primarily affects adults.
May arise from diffuse astrocytoma WHO grade II or de
novo.
Inherent tendency to undergo progression to
glioblastoma.
Clinical features
Similar to those of patients with diffuse astrocytoma
WHO grade II.
Increasing neurological deficits, seizures and signs of
intracranial pressure.
Shorter course, present without clinical evidence of a
preceding astrocytoma WHO grade II.
Localization
Corresponds to that of other diffuse infiltrating
astrocytomas, with a preference for the cerebral
hemispheres.
Macroscopy
Macroscopic cysts are uncommon.
Areas of granularity, opacity and soft consistency.
Discernible tumour mass with a more clear distinction
from surrounding structures than is the case in diffuse
astrocytomas WHO grade II
Histopathology
Diffusely infiltrating astrocytoma with increased cellularity
as compared to the grade II equivalent.
Distinct nuclear atypia and mitotic activity.
Microvascular proliferation (multilayered vessels) and
necrosis are absent.
GFAP immunoreactivity.
Glioblastoma
Variants correspond to WHO grade IV.
The most frequent primary brain tumour.
The most malignant neoplasm with predominant
astrocytic differentiation.
Manifest rapidly de novo.
Invasive nature, cannot be completely resected.
Older age as the most significant adverse prognostic
factor.
Localization
Subcortical white matter of the cerebral hemispheres.
Fronto-temporal.
Infiltration often extends into the adjacent cortex and
through the corpus callosum into the contralateral
hemisphere.
Brain stem (infrequent and often affects children)
Clinical features
The disease is usually short (less than 3 months in
more than 50% of cases)
Signs of raised intracranial pressure.
Seizure. (1/3 patients)
Non-specific neurological symptoms : headache,
personality changes.
Macroscopy
The tumours are often surprisingly large and may
occupy much of a lobe.
The lesion is usually unilateral, but can be bilaterally
symmetrical in the brain stem and corpus callosum.
Variable colour with peripheral greyish tumour masses
and central areas of yellowish necrosis from myelin
breakdown.
Histopathology
Tissue patterns
Secondary structures
Epithelial structures
Cellular composition
Small cell glioblastoma.
Glioblastoma with oligodendroglioma component.
Multinucleated giant cells
Gemistocytes
Granular cells
Lipidized cells
Perivascular lymphocytes
Metaplasia
Microvascular proliferation
Oligodendroglial component in
a GBM
Microvascular proliferation in a
glioblastoma with formation of a
multilayered 'glomeruloid tuft'
Gliosarcoma
Corresponds histologically to WHO grade IV.
characterized by a biphasic tissue pattern with
alternating areas displaying glial and mesenchymal
differentiation.
Gliosarcoma constitutes approximately 2% of all
glioblastoma.
Preferential manifestation between ages 40 and 60,
rare cases in children.
Males are more frequently affected.
Localization
Usually located in the cerebral hemispheres.
Temporal.
Frontal.
Parietal.
Occipital lobes.
Posterior fossa and the spinal cord (rarely).
Clinical features
Symptoms of short duration
Reflect the location of the tumour
Increased intracranial pressure
Associated with prior irradiation
The radiological features are similar to those of
glioblastoma.
Macroscopy
Gross appearance of a firm
Well-circumscribed mass that can be mistaken for a
metastasis or, when attached to the dura, for a
meningioma
Lesions less rich in connective tissue
Histopathology
Biphasic tissue pattern
Malignant transformation : nuclear atypia, mitotic
activity, necrosis ...
Malignant fibrous histiocytoma
Mesenchymal differentiation : the formation of
cartilage, bone, osteoid-chondral tissue, smooth and
striated muscles, lipomatous features.
Gliosarcoma.
(a) Elongated cells are
arranged in fascicles;
mitotic figures are readily
found in these
sarcomatoid neoplasms
which also contain foci of
astrocytic cells.
Gliomatosis cerebri
Corresponds to WHO grade III in a majority of cases.
Most commonly displays an astrocytic phenotype.
(oligodendroglioma and mixed oligoastrocytoma can
also present)
Coined by Nevin in 1938, describe the extensive
involvement of large areas of the brain by glial cells in
the absence of a mass lesion.
Localization
No anatomic site of the brain has been excluded. The
most commonly involved areas,
The cerebral hemispheres (76%), the mesencephalon
(52%), the pons (52%), the thalamus (43%), the basal
ganglia (34%), the cerebellum (29%), the medulla
oblongata (13%), the hypothalamus, the optic nerves
and chiasm, and the spinal cord (each at 9%)
Clinical features
Depending on the cerebral areas infiltrated.
Changes in mental status : dementia, lethargy,
seizures, headache, pyramidal symptoms, cranial nerve
dysfunction
Signs and symptoms of increased intracranial pressure,
spinocerebellar deficits, sensory deficits, paraesthesia,
visual disturbances.
Macroscopy
Swollen and firm
Blurred distinction between grey and white
Histopathology
A proliferation of small glial cells with elongated,
fusiform nuclei.
Obviously astrocytic, and gemistocytic form, classical
morphologic features of oligodendroglioma have also
been described.
Signs of demyelination, but neurons and axons are
intact .
Immunohistochemistry
GFAP and S-100 protein immunostaining results are variable;
in many cases, tumour cells exhibit strong positivity for both
markers, whereas in others a majority of tumour cells are
non-reactive.
Oligodendroglial tumours
Oligodendroglioma
Anaplastic oligodendroglioma
Oligodendroglioma
Constitute 7-10% of primary intracranial neoplasma.
Occur with equal incidence in males and females
Are uncommon in childhood
Occur most frequently in patients aged 30- 50 years
Oligodendroglioma
Occur most often in the frontal lobe
Most often present with epilepsy
Are probabyly more chemossensitive and radiosensitive and
more prone to hemorrhage
Abnormal genetic chromosomes 1p and 19q
Oligodendroglioma
Have a variety of macroscopic appearance
Difficult to locate in resection specimens
Distortion of the normal cortical gray and white matter interface
Discoloration of tissue provide clues to their location.
Oligodendroglioma
- White matter in
the frontal lobe
- Expands the gyri
- Distorting the
lateral ventricles
Oligodendroglioma
Oligodendroglioma
Oligodendroglioma
Oligodendroglioma
Oligodendroglioma
DIFFERENTIAL DIAGNOSIS OF
OLIGODENDROGLIOMA
Non- neoplasm condition: demyelination (small round
nuclei and clear cytoplasm)
Diffuse astrocytoma
- Nuclei more pleomorphism
- Do not have the network of branching capillaries and
cells with perinuclear halos
Oligodendroglioma
Immunohistochemistry:
- Positive: GFAP, S100, MAP2 (strong)
- Negative: EMA
Anaplastic oligodendroglioma
Endothelial hypertrophy
Complex microvascular proliferation
Conspicuous mitotic activity joined
In some cases, by necrosis and often accompanied by dense
cellularity and obvious nuclear atypism.
Anaplastic oligodendroglioma
Oligoastrocytic tumours
The only mixed gliomas broadly recognized by both
neuropathologists and the WHO are those manifesting
astrocytic and oligodendroglial features.
Oligoastrocytoma
Anaplastic oligoastrocytoma
Oligoastrocytoma
Contain tumor cell populations that manifest both oligodendroglial and astroglial phenotypes.
Show a mild degree of pleomorphism and few mitotic gures.
Endothelial proliferation and necrosis are absent.
Anaplastic Oligoastrocytoma
Increased cellularity, nuclear atypia, and high mitotic
activity, microvascular proliferation
Immunohistochemistry
GFAP
Ependymal tumours
Subependymoma
Myxopapillary ependymoma
Ependymoma
Cellular
Papillary
Clear cell
Tanycytic
Anaplastic ependymoma
Ependymomas
< 59% of primary CNS neoplasms
Varies with patient age and presenting location
A majority of intracranial examples arise in childhood,
intramedullary variants more commonly afflict adults.
10% of intracranial neoplasms in the pediatric population
Up to 30% of those encountered in children under 3 years of
age.
At least two-thirds of these childhood tumors are situated
within the fourth ventricle with increased intracranial pressure
secondary to obstructive hydro- cephalus
Ependymoma
Typified by a dense meshwork of fibrillary
cytoplasmic, stromal blood vessels in formations
known as perivascular pseudorosettes
Cellular Ependymoma
Cells with a high nuclear-cytoplasmic ratio.
Few pseudorosettes are present.
Papillary Ependymoma
Microphotograph shows
papillary structures lined by
single and multiple layers of
monomorphic cuboidal tumor
Tanycytic Ependymoma
Myxopapillary Ependymoma
Contain papillary elements in a myxoid background, admixed with
ependymoma-like cells.
Cuboidal cells, sometimes with clear cytoplasm, are arranged around
papillary cores containing connective tissue and blood vessels. The
myxoid areas contain neutral and acidic mucopolysaccharides.
Anaplastic Ependymoma
The diagnosis ofanaplastic ependymoma (WHO Grade
III)requireshypercellularity, cytologic atypia, increased
mitotic activity, andmicrovascular proliferation. The image
shows highly anaplastic tumor cells arranged around a vessel
creating a pseudorosette.
Subependymoma
Account for <10% of ependymomas.
Are generally found in the fourth and lateral ventricles.
Mainly occur in adult patients.
Present with hydrocephalus or may be asymptomatic,
being found at autopsy.
Subependymoma
Bilateral Subependymoma
Immunohistochemistry
Ependymoma
Papillary ependymoma:
Microphotograph shows GFAP
immunoreactivity predominantly in the
pseudorosettes (GFAP 400).
Anaplastic Ependymoma
DIFFERENTIAL DIAGNOSIS OF
EPENDYMOMA
Astrocytoma, oligodendroglioma, medulloblastoma,
central neurocytoma, microcystic/papillary meningioma
The presence of perivascular anuclear zones (pseudorosettes) with fine
fibrillary GFAP-positive processes is the key to differentiating
ependymomas from these neoplasms
Astroblastoma
Papillary tumor of the pineal region
This tumor often expresses cytokeratins (unlike ependymoma), but
only sparse GFAP.
Astroblastoma
Rare neoplasm (<3% primary brain gliomas)
Occurs in the cerebral hemispheres of young adults and
teenage children (median age 11 years, range 1-58 years)
Sensitive radiotherapy
Astroblastoma
Usually a solid uniform mass of firm
Slightly mucoid tissue
Cyst formation can occur
Astroblastoma
Characterized microscopically by two particular features:
Astroblastomatous rosettes
A focal hyalinization of its vascular network
Astroblastomatous rosettes
Astroblastoma
Differential diagnosis
- Ependymoma: more fibrillar, nuclei smaller
Immunohistochemistry: + (GFAP, vimentin, S100), -(CK,
synatophysin)
Angiocentric glioma
Who grade 1 tumor of children and young adults (2 to 70 years,
mean 17 years)
History of intractable epilepsy
Occurs in the superficical cerebral cortex
With features of infiltrating astrocytoma and ependymoma.
Relationship to ependymoma is unclear
Angiocentric glioma
Macroscopically, expand and distort involved brain
Microscopically
Consist of uniform cells with oval or spindle-shape nuclei.
Cytoplasmic are poorly defined, though some cells appear epithelioid
Necrosis and angiogenesis are absent
Dystrophic calcification is rare
Mitotic figures are very rare
Angiocentric glioma
Angiocentric glioma
Angiocentric glioma
Differential diagnosis
- Astroblastoma: discrete borders, epithelioid cells,
vascular sclerosis
- Astrocytoma infiltrating: no pseudorosettes or
subpial palisading
- Ependymoma: enhancing, discrete borders
Immunohistochemistry: + EMA, + GFAP
Pilocytic Astrocytoma
Bipolar cells
Rosenthal fibers
Eosinophilic granular
bodies/
hyaline droplets
PXA
Pleomorphism
significant cellular and
nuclear pleomorphism
Xantho cells
vacuolated tumor cells
containing lipid droplets
Diffuse Astrocytoma
Mild atypia, particularly
nuclear pleomorphism and
hyperchromasia
Fibrillary
Protoplasmic
Gemistocytic
Anaplastic
Astrocytoma
Densely cellular moderate
Nuclear pleomorphism
Increased mitotic activity
Glioblastoma
High cellularity, admixtures of
Gemistocytes,
Fibrillary astrocytes,
Small cells,
Multinucleated giant cells.
Cellular and nuclearanaplasiawhich is the basis of the designation
"multiforme",
Mitoses
Microvascularproliferation, andnecrosis.
Oligodendroglioma
Uniform, round central nuclei
Clear halo
Anaplastic Oligodendroglioma
Cellularity
Atypia
Mitotic
Microvascular proliferation
Necrosis
Oligoastrocytoma
2 phenotypes
Oligodendroglial cells
Astrocytes
Anaplastic
Oligoastrocytoma
Nuclear
atypia/pleomorphism
High cellularity
High mitotic activity
Astroblastoma
Astroblastomatous rosettes
Vascular hyalinization
Ependymoma
Perivascular pseudorosettes
Cellular
Papillary
Clear cell
Tanycytic
Myxopapillary
Anaplastic
W.H.O GRADING
Atypia
AMEN
Mitosis
Necrosis
Endothelial
proliferation